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ABSTRACT Whether proteins or lipids are the primary target sites for general anesthetic action has engendered consider-
able debate. Recent in vivo studies have shown that the S(+) and R(-) enantiomers of isoflurane are not equipotent, implying
involvement of proteins. Bovine serum albumin (BSA), a soluble protein devoid of lipid, contains specific binding sites for
isoflurane and other anesthetics. We therefore conducted 19F nuclear magnetic resonance measurements to determine
whether binding of isoflurane to BSA was stereoselective. Isoflurane chemical shifts were measured as a function of BSA
concentration to determine the chemical shift differences between the free and bound isoflurane. KD was determined by
measuring the 19F transverse relaxation times (T2) as a function of isoflurane concentration. The binding duration was
determined by assessing increases in 1/T2 as a result of isoflurane exchanging between the free and bound states. The S(+)
and R(-) enantiomers exhibited no stereoselectivity in chemical shifts and KD values (KD = 1.3 + 0.2 mM, mean ± SE, for
S(+), R(-), and the racemic mixture). Nonetheless, stereoselectivity was observed in dynamic binding parameters; the S(+)
enantiomer bound with slower association and dissociation rates than the R(-).
INTRODUCTION
One of the prevailing theories on molecular mechanisms of
general anesthesia hypothesizes that proteins, rather than
lipids, are the primary target sites for anesthetic action
(Franks and Lieb, 1994). Principal findings in support of
this theory include (1) that the photon emission from firefly
luciferase, a lipid-free protein, can be inhibited by a variety
of general anesthetics at their respective clinical concentra-
tions (Franks and Lieb, 1984); (2) that some important
ligand-gated ion channels, e.g., nicotinic acetylcholine
(ACh) receptors (Firestone et al., 1986, 1994; Dilger et al.,
1992; Dilger and Liu, 1992) and y-amino butyric acid
(GABAA) receptors (Jones et al., 1992; Lin et al., 1992,
1993b; Nakahiro et al., 1989; Wakamori et al., 1991), are
sensitive to volatile anesthetics at clinical concentrations;
(3) that bovine serum albumin (BSA), another lipid-free
soluble protein, contains a limited number of saturable
binding sites for volatile anesthetics such as halothane and
isoflurane (Dubois and Evers, 1992; Dubois et al., 1993);
and (4) that optically pure enantiomers of isoflurane exhibit
different anesthetic potencies in vivo (Harris et al., 1992;
Lysko et al., 1994). Although no protein in the central
nervous system (CNS) has yet been positively identified as
the target site for general anesthesia, numerous examples
exist wherein the activity of a protein is profoundly affected
by a single small effector molecule. It is thus conceivable
that the function of some crucial proteins in the CNS can be
altered by anesthetic binding. This concept has motivated
extensive investigation to determine anesthetic-protein in-
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teractions at the cellular and molecular levels (Abadji et al.,
1993; Dickinson et al., 1993; Dilger and Brett, 1991; Dilger
and Liu, 1992; Dilger et al., 1993, 1994; Dubois and Evers,
1992; Hall et al., 1994; Harrison et al., 1993; Jones et al.,
1992; Jones and Harrison, 1993; Lin et al., 1993a,b; Zim-
merman et al., 1994), despite the confounding possibility
that anesthetic actions on proteins may result from indi-
rect actions mediated by changes in the surrounding lipids
(Fraser et al., 1990; Abadji et al., 1993).
Stereoselective anesthetic action is one of the few tests
for the protein theory; stereoselectivity usually suggests
direct and specific receptor-mediated action (Franks and
Lieb, 1991, 1994; Hall et al., 1994; Harris et al., 1992, 1994;
Lysko et al., 1994; Moody et al., 1993, 1994; Eckenhoff and
Shuman, 1993). Therefore, it is important to evaluate the
intrinsic ability of anesthetic enantiomers to interact with
pure proteins. In this study, we examined the binding of the
two optical enantiomers of isoflurane to BSA, using 19F
nuclear magnetic resonance (NMR) spectroscopy and gas
chromatography (GC). We predicted that the binding would
be stereoselective, as suggested by other physical (Ecken-
hoff and Shuman, 1993) and indirect (Franks and Lieb,
1991; Jones and Harrison, 1993) methods.
MATERIALS AND METHODS
Materials
Racemic isoflurane was purchased from Abbott Laboratories (North Chi-
cago, IL). Optically pure enantiomers, S(+) and R(-), were generously
provided by J. Vernice of Anaquest (Murray Hill, NJ). Lyophilized BSA
(fraction V, fatty acid free) was obtained from Sigma Chemical Co. (St.
Louis, MO). Other chemicals, of analytical reagent grade, were purchased
from Sigma and Mallinckrodt (Paris, KY). All agents were used without
further purification.
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Preparation of saturated isoflurane solution
Saturated solutions of S(+), R(-), or racemic isoflurane were prepared by
mixing, at 40C and in gas-tight vials, an excess amount (typically 130 IlI)
of neat isoflurane in 50 ml of Hepes buffer solution, containing 135 mM
KCI, 15 mM sodium gluconate, 1 mM EDTA, 0.75 mM CaCl2, and 10 mM
glucose. Saturation was confirmed by the presence of residual neat isoflu-
rane and by repeated GC measurements showing constant isoflurane con-
centrations of 14.2 ± 0.1, 14.1 ± 0.1, and 14.4 ± 0.2 mM (mean ± SD)
for S(+), R(-), and the racemic mixture, respectively, at room tempera-
ture.
Preparation of BSA solutions
Lyophilized BSA (Mr = 66.2 X 103) was dissolved in the Hepes buffer by
gentle magnetic stirring at 40C. The concentrations used in NMR and GC
measurements ranged from 0.75 mg/ml (11.3 pM) to 90 mg/ml (1.4 mM). To
separate specific binding at the fatty-acid-replaceable sites from nonspecific
binding, NMR measurements (see below) were also carried out to determine
any residual isoflurane binding to BSA when the latter was either acidified
with HCl to pH 2.5 or complexed to oleic acid at an oleic-acid-to-BSA molar
ratio of 6 to 1. To prepare the oleic-acid-BSA complex, a measured amount of
sodium oleate was first dissolved in distilled water and then added to a given
BSA solution, as described by Spector (1986).
GC techniques and Xb calculations
Saturated isoflurane solution, BSA stock solution, and Hepes buffer were
mixed in gas-tight vials such that the final aqueous volumes occupied
one-half of the vial's total volume (1 ml). The mixtures were allowed to
equilibrate at room temperature for 24 h. The BSA concentrations ranged
from 0 to 75 mg/ml. The nominal initial isoflurane concentration was 4
mM, which, after equilibration, resulted in a final aqueous isoflurane
concentration comparable to that used in the corresponding NMR studies
(see below). Aliquots (2 ,ul) of liquid sample were withdrawn using a
gas-tight syringe (Hamilton) and were quantified by GC (Perkin-Elmer
8500; Poropak P resin; 150°C).
Based on the GC measurements, the fraction of isoflurane bound to
BSA, Xb, was calculated using the method described in detail by Dubois
and Evers (1992).
Binding analysis by NMR measurements
There are at least two possible environments for isoflurane in a BSA
solution: a bound environment and an aqueous, free environment. When
isoflurane exchanges fast enough between these environments, resonance
peaks that characterize each of the environments coalesce to give rise to a
single resonance (Trudell and Hubbell, 1976). The observed chemical
shifts and T2 of this coalesced resonance contain weighted contributions
from the two environments and thus can be used for binding analysis
(Fraenkel et al., 1990; Dubois and Evers, 1992).
Chemical shifts are sensitive indicators of the chemical environment in
which resonating nuclei reside. The limiting shift for the isoflurane in the
bound environment is thus characteristic of the binding sites. Let (f and Lb
be the limiting shifts of the free and bound isoflurane, respectively, and 8
be the observed shift. It can be shown that
1 1 /aft KD
-6fb6 f\ [R]j (1)
where [R] is the equilibrium BSA concentration, and KD is the dissociation
constant of the isoflurane-BSA complex. Thus, if chemical shifts are
measured as a function of BSA concentration at a fixed isoflurane con-
centration, the weighting for the two-site averaging is shifted toward the
bound environment. At high BSA concentrations, [R1 can be approximated
by the initial BSA concentration, [R]O. By extrapolating the reciprocal of
the measured relative chemical shifts to l/[R]O -> 0 (corresponding to Xb
= 1), the limiting chemical shift for the bound isoflurane can be deter-
mined.
Theories have been developed (Dwek, 1973) to account for T2 relax-
ation in a two-site system where relaxation due to exchange between the
sites is not negligible. It has been shown (Allerhand and Gutowsky, 1965)
that when the CPMG method is used, the observed T2 is a function of the
180-180° interpulse delay Tcp:
1 -Xb
T2 T2f Tb+ + TbXb(l - Xb)(5o))2f(ICP)
(2)
where T2f and T2b are the intrinsic T2 of isoflurane in the free and the bound
states, respectively, 6w = 2ir(Sb - (f) is the chemical shift difference
between the free and bound isoflurane, Tb is the lifetime of isoflurane in the
bound state, and f(Tcp) is a hyperbolic tangent:
f(Tcp) = 1 - tanh 2NMR techniques Tcp 2Ti,
All samples for NMR were prepared by mixing measured amounts of
saturated isoflurane solution, BSA stock solution, and the Hepes buffer
directly inside 5-mm, high precision NMR tubes (Wilmad Glass Co.,
Buena, NJ), which were capped and almost completely filled to minimize
volatile anesthetic loss from the aqueous phase. A tiny air bubble, <1% of
the tube volume, was intentionally left in the tubes for the purpose of
inversion mixing. All '9F NMR experiments were conducted using an
Otsuka-Chemagnetics (Fort Collins, CO) CMXW-400 spectrometer oper-
ating at 377.168 MHz. The resonance frequencies of isoflurane were
measured as chemical shifts (in units of parts per million, ppm) relative to
an external reference of diluted CF3COOH solution contained in a 10-mm
NMR tube coaxial to the 5-mm sample tubes. The transverse relaxation
time (T2), which characterizes the motional restriction of isoflurane mol-
ecules, was measured using the conventional Carr-Purcell-Meiboom-Gill
(CPMG) spin-echo method (Meiboom and Gill, 1958). In this method, a
900 radiofrequency pulse is given to prepare the 19F nuclei, which are then
refocused repeatedly by a series of 1800 pulses to create a train of spin
echoes. The echo maxima were digitized and T2 calculated from nonlinear
regression of the echo maxima using exponential decay functions. In our
experiments, the pulse lengths for the 900 and 1800 pulses were 27 ,us and
54 ,us, respectively. The time between the consecutive 1800 pulses, Tcp,,
ranged from 60 ,ts to 4 ms.
After Xb and Sw are determined, nonlinear regression of measured l/T2 as
a function of I/T-,1p using Eq. 2 will generate the best estimates of T2b and
Tb-
Initial values of the fitting parameters often influence the goodness of
nonlinear regression (Glantz and Slinker, 1990a). For Eq. 2, two limiting
cases can be considered for the initial estimate of Tb. In the slow pulsing
limit, Tcp >> Tb, f(Tcp) -> 1, and Eq. 2 becomes
l-Xb Xb1 1 Xb + b + TbXb(I - Xb)(6O)2
2 T2f T2b + Tb
In the fast pulsing limit, TCP << Tb, f(TrP) -> 0, and
1 -Xb Xb
= +
1'2 T2f T2b + Tb
(4)
(5)
Equations 4 and 5 define the upper and lower limits of l/T2. The difference
between the two limits is proportional to Tb.
In this study, T2b and Tb were determined at an isoflurane concentration
of 1.65 mM and BSA concentrations of 0.75, 1.75, and 6.00 mg/ml.
Repeated T2 measurements were made with variable 'Tnp ranging from 60
,uAs to 4 ms. With the knowledge ofXb from the GC measurements, bSw from
(3)
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the chemical shift measurements, and T2f from the T2 measurements in the
BSA-free buffer, the best estimates of T2b and Tb were obtained from
nonlinear regression using Eq. 2.
In addition to T2b and Tb, Eq. 5 can be rearranged to determine KD. By
expressing Xb in terms of KD, it follows that (Dubois and Evers 1992)
T2b Rb[A]O T2b +Rb KD
-2 [R]0 [R]0
where [A]O is the initial concentration of isoflurane and
T2p = (1/T2 -/T2f)-'
(6)
S(+)
...........
.......S.
(7)
is the additional relaxation due to binding. Hence, T2P[R]O is a linear
function of [A]O, having a slope of T2b + Tb and an intercept on the x axis
of -KD.
In this study, KD was determined by repeated T2 measurements at six
different isoflurane concentrations (ranging from 0.82 to 4.94 mM) and
three BSA concentrations (0.75, 1.75, and 6.00 mg/ml). The echo timeTcp
was fixed at 100 ,us for these experiments. A total of 78 samples were
measured: 24 for S(+), 31 for R(-), and 23 for the racemic mixture.
Depending on the signal-to-noise ratio of each measurement, the number of
acquisitions averaged ranged from 32 to 256. For most of the samples, the
measurements were repeated two or three times.
To determine the KD at the fatty-acid-replaceable sites (i.e., KD of
specific binding), the T2f values used in Eq. 7 for T2p calculation were those
obtained separately at the above three BSA concentrations when the BSA
was complexed with oleic acid (oleic acid:BSA = 6:1).
Statistical analysis
Student's t-test was used to compare Xb of the two enantiomers for a
significance level ofp = 0.05. To compare KD and T2b + Tb between S(+)
and R(-), the t statistics were calculated for the x intercepts and the slopes
of the two regression lines using Eq. 6. The t statistic is the ratio of the
difference of the two slopes or intercepts to the standard error of the
difference. Because different numbers of samples were measured for the
S(+) and R(-), the standard error of the difference is computed by using
a pooled variance, which is a weighted average based on the degrees of
freedom in each case (Glantz and Slinker, 1990b; Glantz, 1992). The
calculated t was then compared with the critical value of t, tr, for the
corresponding degrees of freedom in the measurements. A p value of less
than 0.05 was considered as statistically significant.
RESULTS
Chemical shift measurements at various BSA concentra-
tions revealed no differences between the S(+) and R(-)
enantiomers or the racemic mixture. Fig. 1 A shows repre-
sentative 19F-NMR spectra of 1.65 mM S(+), R(-), and
racemic isoflurane (peaks at -4.24 and -10.11 ppm) in 75
mg/ml BSA solutions. All shifts were measured relative to
the common external reference (CF3COOH, peaks at 0
ppm) in the 10-mm coaxial tube to determine the chemical
shift differences. The inset to Fig. 1 a expands the region of
the trifluoromethyl resonance, showing essentially the same
chemical shifts for the two enantiomers and the racemic
mixture. This was also true at other BSA concentrations
studied, ranging from 0 to 90 mg/ml (corresponding to Xb of
0 to 0.7; Dubois and Evers, 1992).
Fig. 1 b depicts the reciprocal of relative changes in
chemical shift as a function of the reciprocal of the initial
BSA concentration for 1.65 mM S(+), R(-), and racemic
Racennic .
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FIGURE 1 (a) Representative 19F NMR spectra of 1.65 mM S(+),
R(-), and racemic isoflurane in 75-mg/ml BSA solutions. The inset
expands the region of isoflurane's trifluoromethyl resonance near -4.24
ppm, showing the same chemical shifts relative to the common external
reference (CF3COOH, peaks at 0 ppm). (b) Plot of 1/(S 8f) as a function
of 1/[R]O. Extrapolation of 1/[R]O to 0 yields b- f = 0.50 ± 0.02 ppm
(Eq. 1). 0, S(+); 0, R(-); L], racemic. (c) Comparison of fraction of
bound isoflurane, Xb, for 1.65 mM S(+), R(-), and racemic isoflurane in
6- and 75-mg/ml BSA solutions, showing no significant difference in Xb
between S(+) and R(-). Error bars indicate standard deviations (n = 7).
isoflurane. The solid lines, which overlap one another, are
linear least-squares fit to the data (Eq. 1). The y intercepts
yield &co/2ir = Sb- f = 0.50 + 0.02 ppm. Although the
a
j-T 4-j .5 "
-3 -4 -5
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slopes are proportional to KD, difficulties in determining
equilibrium BSA concentrations exclude the use of this
method for accurate KD measurement. Nevertheless, the
same slopes for the S(+), R(-), and racemic isoflurane
suggest that the KD is the same for the two enantiomers.
The fraction of bound isoflurane (Xb) was determined at
various BSA concentrations. Fig. 1 c compares the Xb for
1.65 mM of either S(+), R(-), or racemic isoflurane in both
6- and 75-mg/ml BSA solutions. There was no significant
difference in Xb between the two enantiomers (p > 0.05, n
- 7).
Fig. 2 shows KD analysis using Eq. 6 from repeated T2
measurements at different initial isoflurane concentrations.
To determine KD at only the fatty-acid-replaceable binding
sites, T2p was calculated by replacing the T2f in Eq. 7 with
the T2 measured in oleic-acid-complexed BSA solutions
(oleic acid:BSA = 6:1), so that any additional relaxation
caused by nonspecific (i.e., oleic-acid-insensitive) binding
was canceled. The inset to Fig. 2 depicts individual mea-
surements at BSA concentrations of 0.75, 1.75, and 6 mg/ml
for S(+), R(-), and racemic isoflurane, whereas the main
plot summarizes all T2p[R]O as a function of initial isoflu-
rane concentrations, where [R]o is the nominal initial BSA
concentrations in mM. The solid lines in the figure are linear
regression -to the data. According to Eq. 6, the slope and the
intercept on the x axis of the regression lines are, respec-
tively, the best estimates of T2b + Tb and -KD. These
parameters are summarized in Table 1. Student's t-test on
the two regression lines for the S(+) and R(-) enantiomers
showed significant difference in the slopes (tslope = 17.56,
p < 0.001) but no significant difference in the intercepts
(tintercept = 0.33, p > 0.5).
10
FIGURE 2 KD analysis based on re-
peated T2 measurements (Eq. 6). Inset:
T2p is plotted as a function of initial
isoflurane concentration in 0.75-,
1.75-, and 6.00-mg/ml BSA solutions.
Main plot: Summary of T2p[R]O as a
function of initial isoflurane concentra-
tion. The T2f values used for T2p calcu-
lation were the T2 values measured in
the oleic-acid-complexed BSA solu-
tions of the respective concentrations.
Error bars are standard deviations (SD)
of the measurements at each isoflurane
concentration. Where there are no error
bars, the SD is smaller than the size of
the symbol. Solid lines are linear re-
gression to the data. The slope and the
intercept on the x axis of the regression
lines are, respectively, the best esti-
mates of T2b + Tb and -KD (Eq. 6). 0,
S(+); O, R(-); El, racemic.
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TABLE 1 Comparison of S(+), R(-), and racemic isoflurane
binding to BSA
(KD)SpecifiC
(T2b + Tb)specific (mM),* T2b (ms), Tb (pS),t
(ms),* Eq. 6 Eq. 6 Eq. 2 Eq. 2
S(+) 1.18 ± 0.05 1.29 ± 0.20 3.7 ± 0.1 230 ± 17
S + R 1.27 ± 0.08 1.26 ± 0.26 4.4 ± 0.1 215 ± 10
R(-) 1.37 ± 0.06 1.28 ± 0.21 5.2 ± 0.3 191 ± 13
*Data shown are best estimates ± standard error of the estimates from
linear regression, Eq. 6. The subscript specific is used to indicate that the
measured parameters are for binding at the fatty-acid-replaceable sites.
tData shown are mean ± SD of four separate measurements at BSA
concentrations of 0.75 (n = 1), 1.75 (n = 1), and 6 (n = 2) mg/ml.
Fig. 3 depicts measured l/T2 as a function of interpulsing
rate l/Tcp for 1.65 mM isoflurane at three BSA concentra-
tions (0.75, 1.75, and 6 mg/ml). The solid lines are nonlinear
regressions of the data using Eq. 2. In the regression, the
limiting chemical shift of 190 Hz, determined from extrap-
olation of measured chemical shifts at different BSA con-
centrations, and T2f measured in BSA-free buffer solutions
(1.51 ± 0.02, 1.56 ± 0.03, and 1.52 ± 0.02 s for S(+),
R(-), and racemic isoflurane, respectively), were used.
Because no significant difference in Xb was found between
S(+) and R(-) enantiomers, Xb values measured with the
racemic isoflurane at the three BSA concentrations (see
above, also Dubois and Evers, 1992) were used in the
regression. The results of the fitting are also given in Table
1. Although the apparent equilibrium dissociation constants
were the same within experimental errors for the two enan-
tiomers, the binding dynamics, as characterized by T2b and
Tb, was significantly different (p < 0.01).
-2 -1 0 1 2 3 4 5
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FIGURE 3 Dependence of l/T2 of trifluoromethyl resonance of S(+)
(S), R(-) (0), and racemic (O) isoflurane (1.65 mM) on pulse repetition
rate, 1/1P. BSA concentrations are as indicated. (n = 1 for 0.75 and 1.75
mg/ml; n = 2 for 6 mg/ml. Error bars indicate SD.) At a given Xb, the
A(1I/T2) between the fast-pulsing (1/Tcp'-- m0) and the slow-pulsing (1/Tcp
-- 0) limits is proportional to Tb. Note the difference in limiting A(1/T2)
between S(+) and R(-) at the same BSA concentrations. Solid lines are
nonlinear regression of data using Eq. 2, yielding the best estimates of Tb
and T2b.
DISCUSSION
Because there were no chemical shift differences between
the S(+) and R(-) enantiomers over a wide range of BSA
concentrations, extrapolation of 1/[R]o -> 0 (Xb -> 1) re-
sulted in the same limiting shifts for the two enantiomers in
the bound state. This finding strongly suggests that the S(+)
and R(-) enantiomers bind to the same sites (i.e., the same
microenvironments) on BSA. Moreover, because the KD
values were the same, the equilibrium concentrations of the
two enantiomers at these sites must also have been the same.
Therefore, for these parameters, our results showed no
stereoselectivity in isoflurane binding to BSA.
Our experiments, however, did reveal stereoselectivity in
dynamic parameters; the S(+) enantiomer had a faster re-
laxation rate (smaller T2b) and a longer lifetime (greater Tb)
in the bound state than the R(-). Under our experimental
conditions, T2 reflected motional restriction of the mole-
cules bearing the nuclei under investigation (e.g., 19F). In
general, a shorter T2 indicates a less mobile environment for
the nuclei. Because T2b for S(+) was significantly shorter
than for R(-), motion while bound was more restricted for
S(+) than for R(-). This was true for specific binding
alone, as assessed from the slopes in Fig. 2, or for the
combination of specific and nonspecific binding, as calcu-
lated from the nonlinear regression in Fig. 3. It should be
pointed out that for both enantiomers, motion was more
restricted at the specific binding sites than at the nonspecific
sites, as T2b obtained from Fig. 2 was shorter than that from
Fig. 3 (Table 1).
Examination of the lifetime of the S(+) and R(-) enan-
tiomers at the low affinity (nonspecific) binding sites (at pH
2.5) showed no significant difference in Tb. If a Tb value of
60 ,As is used for low affinity binding (Dubois and Evers,
1992) and 30% of the total binding is assumed to occur at
the low affinity sites (Dubois and Evers, 1992), then the Tb
values for high affinity binding can be calculated, using the
values listed in Table 1, to be ((231 - 60 X 0.3)/0.7) = 304
,As and ((191 - 60 X 0.3)/0.7) = 247 ,us for the S(+) and
R(-) isoflurane, respectively. Thus, at the high affinity
sites, the dissociation rate constant, k0ff, can be estimated to
be 3.3 X 103 and 4.1 X 103 S-1, and the association rate
constant, kon = kof0KD, to be 2.6 X 106 and 3.2 X 106 M-1
s-' for the S(+) and R(-) isoflurane, respectively. Because
k0ff measures the strength of the binding, these results are
consistent with the shorter T2b (less mobility) found for the
S(+) enantiomer.
KD measurement based on Eq. 6 requiresTscp << Tb. In our
experiment, a Tcp of 100 ,us was used, which was not
significantly smaller than the Tb for the specific binding
estimated above. Possible errors introduced by using Eq. 6
can be estimated using Eqs. 2 and 3. For Tcp = 100 lus and
Tb = 250 As, it can be calculated from Eq. 3 that ftTcp)
0.01, and the relative error in I/T2P by neglecting the third
term in Eq. 2 is <0.4%.
Using photoaffinity labeling, Eckenhoff and Shuman
(1993) found that S(+) isoflurane was 50% more effective
than R(-) isoflurane in inhibiting halothane binding to
BSA. They also found that inhibition by the racemic mix-
ture of isoflurane was very similar to that by S(+). Because
the inhibition constant KI is a measure of KD for the disso-
ciation of the isoflurane-BSA complex, their results might
appear to contradict ours. However, photoaffinity labeling is
an intrinsically nonspecific method for any binding with KD
of -1 mM or greater (Ruoho et al., 1984). In fact, the ratio
of nonspecific to specific incorporation in BSA can be
estimated to exceed 500:1, assuming an average molecular
weight of 100 for an amino acid and 66,200 for the protein.
Therefore, the majority of 14C labeling is at the nonspecific
sites. As a consequence, a lesser 14C-halothane incorpora-
tion in the presence of a competitor (e.g., isoflurane) is
likely due to an excessive photolysis reaction of the com-
petitor at the nonspecific sites, leaving fewer nonspecific
sites for 14C-halothane labeling. For the same reason, any
differences in photolysis rates between the two optical en-
antiomers may contribute to the observed difference in the
apparent KI.
In a series of 19F NMR studies (Dubois and Evers, 1992;
Dubois et al., 1993), Dubois and co-workers investigated
the binding of racemic isoflurane and several other fluori-
nated anesthetics to BSA. Our results on chemical shifts, Xb,
and T2 with racemic isoflurane were in good agreement with
theirs. Although BSA plays no mechanistic role in general
anesthesia, the low affinity of anesthetic binding to BSA
may represent a general mode of anesthetic-protein interac-
tion in vivo, where the anesthetics exchange rapidly among
various molecular and cellular compartments. Therefore, in
contrast to the static view of anesthetic agents bound to
certain clefts in a crucial protein, general anesthesia may
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reflect a dynamic process between anesthetics and proteins
(Dilger et al., 1994). The dynamic association rate constant,
kon, is an indicator of the goodness of fit between an
anesthetic and its protein target, whereas the dissociation
rate constant, koff, is a reflection of the strength of binding.
Thus, although the effects of an anesthetic on a given
protein are dependent on the equilibrium effective concen-
tration (e.g., EC50), the details of the anesthetic-protein
interaction (comprised by the kon and koff) may be much
more revealing. For example, the S(+) enantiomer could
bind to the pore of a channel protein with longer duration
(smaller koff) to produce a stronger effect, even when the KD
appeared the same because of a slower association rate
(smaller kon). Differences in binding and dissociation rates
have been suggested to be the basis of a unitary mechanism
of action of ether, isoflurane, and propofol on ACh receptor
channel conductance (Dilger et al., 1994). We have shown
that such differences can also account for the observation of
stereoselectivity in vitro, and may do so in vivo.
In conclusion, isoflurane binding to BSA is stereoselec-
tive. Stereoselectivity results from the differences in the
rates at which the enantiomers bind to and dissociate from
the high affinity binding sites in BSA.
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